Deskside with Dr. Dan
FDA approves first cell-based gene therapy for adult patients with relapsed or refractory mantle cell lymphoma
In January 2021, Dr. Dan explains this new therapy option for relapsed or refractory mantle cell lymphoma patients.
Liz Hiles
October 6, 2022
